Search Results - "Schooley, R T"

Antiretroviral Therapies in Women after Single-Dose Nevirapine Exposure by Lockman, S, Hughes, M.D, McIntyre, J, Zheng, Y, Chipato, T, Conradie, F, Sawe, F, Asmelash, A, Hosseinipour, M.C, Mohapi, L, Stringer, E, Mngqibisa, R, Siika, A, Atwine, D, Hakim, J, Shaffer, D, Kanyama, C, Wools-Kaloustian, K, Salata, R.A, Hogg, E, Alston-Smith, B, Walawander, A, Purcelle-Smith, E, Eshleman, S, Rooney, J, Rahim, S, Mellors, J.W, Schooley, R.T, Currier, J.S

“…A challenge associated with single-dose nevirapine to prevent mother-to-child transmission of HIV is the emergence of nevirapine-resistant HIV. In this study,…”
Get full text

Phage Therapy for a Multidrug-Resistant Acinetobacter baumannii Craniectomy Site Infection by LaVergne, Stephanie, Hamilton, Theron, Biswas, Biswajit, Kumaraswamy, M, Schooley, R T, Wooten, Darcy

“…Abstract In the era of antibiotic resistance, alternative treatment options for multidrug-resistant bacterial infections are being explored. We present a case…”
Get full text

Antiretroviral Therapy in Adults: Updated Recommendations of the International AIDS Society–USA Panel by Carpenter, Charles C. J, Cooper, David A, Fischl, Margaret A, Gatell, Jose M, Gazzard, Brian G, Hammer, Scott M, Hirsch, Martin S, Jacobsen, Donna M, Katzenstein, David A, Montaner, Julio S. G, Richman, Douglas D, Saag, Michael S, Schechter, Mauro, Schooley, Robert T, Thompson, Melanie A, Vella, Stefano, Yeni, Patrick G, Volberding, Paul A

“…OBJECTIVE To update recommendations for antiretroviral therapy for adult human immunodeficiency virus type 1 (HIV-1) infection, based on new information and…”
Get full text

Antiretroviral Therapy for HIV Infection in 1998: Updated Recommendations of the International AIDS Society–USA Panel by Carpenter, Charles C. J, Fischl, Margaret A, Hammer, Scott M, Hirsch, Martin S, Jacobsen, Donna M, Katzenstein, David A, Montaner, Julio S. G, Richman, Douglas D, Saag, Michael S, Schooley, Robert T, Thompson, Melanie A, Vella, Stefano, Yeni, Patrick G, Volberding, Paul A

“…OBJECTIVE.— To provide recommendations for antiretroviral therapy based on information available in mid-1998. PARTICIPANTS.— An international panel of…”
Get full text

Breaking the camel's back : Multicenter clinical trials and local institutional review boards by BURMAN, William J, REVES, Randall R, COHN, David L, SCHOOLEY, Robert T

“…Clinical research has undergone remarkable and beneficial expansion in the past 25 years, but with this growth has come an unprecedented increase in workload…”
Get full text

Does Lipid Emulsion Reduce Amphotericin B Nephrotoxicity? A Systematic Review and Meta-analysis by Mistro, Sóstenes, de M. Maciel, Isis, de Menezes, Rouseli G., Maia, Zuinara P., Schooley, Robert T., Badaró, Roberto

“…This meta-analysis of 13 studies revealed that amphotericin B delivered as a locally prepared lipid emulsion or in liposomes reduced nephrotoxicity to a…”
Get full text

The new paradigm of hepatitis C therapy: integration of oral therapies into best practices by Afdhal, N. H., Zeuzem, S., Schooley, R. T., Thomas, D. L., Ward, J. W., Litwin, A. H., Razavi, H., Castera, L., Poynard, T., Muir, A., Mehta, S. H., Dee, L., Graham, C., Church, D. R., Talal, A. H., Sulkowski, M. S., Jacobson, I. M.

“…Summary Emerging data indicate that all‐oral antiviral treatments for chronic hepatitis C virus (HCV) will become a reality in the near future. In replacing…”
Get full text

Longer-Term Immunologic Effects and Side Effects of Successful Antiretroviral Therapy by Schooley, Robert T.

“…With the development of more potent and better tolerated antiretroviral regimens, durable antiviral responses are being observed in an increasing fraction of…”
Get full text

Antiretroviral effect and safety of abacavir alone and in combination with zidovudine in HIV-infected adults by SAAG, M. S, SONNERBORG, A, TORRES, R. A, LANCASTER, D, GAZZARD, B. G, SCHOOLEY, R. T, ROMERO, C, KELLEHER, D, SPREEN, W, LAFON, S

“…Objectives: To evaluate, over 12 weeks, the antiretroviral activity and safety of abacavir, used alone and in combination with zidovudine (ZDV), as treatment…”
Get full text

Virologic and Immunologic Benefits of Initial Combination Therapy with Zidovudine and Zalcitabine or Didanosine Compared with Zidovudine Monotherapy by Schooley, Robert T., Ramirez-Ronda, Carlos, Lange, Joep M. A., Cooper, David A., Lavelle, James, Lefkowitz, Lewis, Moore, Mark, Larder, Brendan A., Clair, Marty St, Willem Mulder, Jan, McKinnis, Ray, Pennington, Kevin N., Harrigan, P. Richard, Kinghorn, Ian, Steel, Helen, Rooney, James F.

“…A randomized controlled study was done to determine whether initial combination therapy with zidovudine and zalcitabine or zidovudine and didanosine would…”
Get full text

CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine by SUNGSUB CHOI, LAGAKOS, S. W, SCHOOLEY, R. T

“…To determine the extent to which lymphocytes, particularly those with the CD4 surface antigen, are a surrogate marker for the development of the acquired…”
Get full text

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial by Fischl, M A, Richman, D D, Grieco, M H, Gottlieb, M S, Volberding, P A, Laskin, O L, Leedom, J M, Groopman, J E, Mildvan, D, Schooley, R T

“…We conducted a double-blind, placebo-controlled trial of the efficacy of oral azidothymidine (AZT) in 282 patients with the acquired immunodeficiency syndrome…”
Get more information

Human immunodeficiency virus neutralizing antibodies recognize several conserved domains on the envelope glycoproteins by HO, D. D, SARNGADHARAN, M. G, HIRSCH, M. S, SCHOOLEY, R. T, ROTA, T. R, KENNEDY, R. C, CHANH, T. C, SATO, V. L

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Long-Term Culture and Fine Specificity of Human Cytotoxic T-Lymphocyte Clones Reactive with Human Immunodeficiency Virus Type 1 by Walker, Bruce D., Flexner, Charles, Birch-Limberger, Karen, Fisher, Laura, Paradis, Timothy J., Aldovini, Anna, Young, Richard, Moss, Bernard, Schooley, Robert T.

“…The definition of human immunodeficiency virus type 1 (HIV-1) immunogenic epitopes is central to the rational design of AIDS vaccine strategies. In this study,…”
Get full text

CD4 cell count as a surrogate endpoint in HIV clinical trials : a meta-analysis of studies of the AIDS Clinical Trials Group by HUGHES, M. D, DANIELS, M. J, FISCHL, M. A, SOYEON KIM, SCHOOLEY, R. T

“…To evaluate initial changes in CD4 cell count as a surrogate endpoint for clinical outcome in HIV-infected patients. Meta-analysis of all relevant Phase II and…”
Get full text

Correlation between viral load measurements and outcome in clinical trials of antiviral drugs by Schooley, R T

“…As evidence is emerging that viral load can be correlated with clinical outcome in HIV-infected patients, new assays have been developed to measure viral load…”
Get more information

Treatment for Adult HIV Infection: 2004 Recommendations of the International AIDS Society-USA Panel by Yeni, Patrick G, Hammer, Scott M, Hirsch, Martin S, Saag, Michael S, Schechter, Mauro, Carpenter, Charles C. J, Fischl, Margaret A, Gatell, Jose M, Gazzard, Brian G, Jacobsen, Donna M, Katzenstein, David A, Montaner, Julio S. G, Richman, Douglas D, Schooley, Robert T, Thompson, Melanie A, Vella, Stefano, Volberding, Paul A

“…CONTEXT Substantial changes in the field of human immunodeficiency virus (HIV) treatment have occurred in the last 2 years, prompting revision of the…”
Get full text

HIV-specific cellular and humoral immune responses in primary HIV infection by Connick, E, Marr, D G, Zhang, X Q, Clark, S J, Saag, M S, Schooley, R T, Curiel, T J

“…Primary human immunodeficiency virus (HIV) infection is characterized by a high-titer viremia that declines precipitously within weeks, most likely as a result…”
Get more information

Vidarabine versus acyclovir therapy in herpes simplex encephalitis by Whitley, R J, Alford, C A, Hirsch, M S, Schooley, R T, Luby, J P, Aoki, F Y, Hanley, D, Nahmias, A J, Soong, S J

“…We randomly assigned 208 patients who underwent brain biopsy for presumptive herpes simplex encephalitis to receive either vidarabine (15 mg per kilogram of…”
Get more information

Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3 by Hibberd, P L, Tolkoff-Rubin, N E, Cosimi, A B, Schooley, R T, Isaacson, D, Doran, M, Delvecchio, A, Delmonico, F L, Auchincloss, Jr, H, Rubin, R H

“…A prospective study to investigate risk factors for CMV disease was conducted in 94 renal transplant recipients. CMV disease was defined as either unexplained…”
Get more information